glp 1 drugs and menopause Postmenopausal women on the GLP-1 medication tirzepatide (Zepbound) for obesity lost more weight if they were also using hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 Let’s talk about GLP-1 medications
Description
DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption
Common brands of GLP-1 medication include Ozempic and Wegovy
Juli-Romero C, Palau-Mart C, Tejedor-Bosqued A

1.0 mm lateral to bregma) (David Kopf Instruments)

Figure 1 illustrates the diverse physiological effects of GLP-1RAs across major organ systems, including the pancreas, liver, brain, cardiovascular system, kidneys, gastrointestinal tract, and adipose tissue

14% in placebo-treated individuals
